CNBGChina National Biotech Group (China)
CNBGCanadian National Buying Group (Ontario, Canada)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
CNBG has many unique inventions and is currently operating in more than one hundred SFDA cGMP accredited manufacturing lines with the capability of manufacturing over 200 types of biological products for disease prevention, therapeutic and diagnostic use, including all the vaccines for the Chinese EPI program.
The pneumococcal vaccine partnership deal between CNBG and ImmBio will help to speed up the development process to produce an effective pneumococcal vaccine to fight the infection on a global scale.
CNBG is the biological product arm of Sinopharm, China's largest pharmaceutical and healthcare group in China, with core business in pharmaceutical distribution, scientific research and manufacture of medical and biotech products.
Under the research collaboration, Riboxx will offer access to Riboxxim to allow CNBG to perform an evaluation, in collaboration with China National Biotec Group's antigen, against the disease target.
Lan Yun, president, Carrier Network Business Group (CNBG), Huawei Middle East tells CommsMEA how Huawei is working towards creation of new opportunities for the telcos.
Town & Country Hardware recently joined the Central Network Retail Group, LLC (CNBG).
Limited, Bio-Manguinhos - Institute of Technology on Immunobiologicals, BioNet-Asia Co., Ltd., Cadila Pharmaceuticals Limited, Center for Genetic engineering and Biotechnology Chengda Liaoning, China National Biotec Group (CNBG).
10 January 2012 - Aeras, a US-based non-profit product development organisation engaged in the development of tuberculosis (TB) vaccines, and the China National Biotec Group (CNBG) announced on Tuesday that they had signed a collaboration agreement for the joint development of new TB vaccines.
A number of research institutes that operate under the umbrella of CNBG, China's largest biotechnology corporation, will team up with Aeras on drafting a joint strategy aimed at developing, manufacturing and distributing affordable new TB vaccines around the world.